HomeCompareSHIEF vs PLD

SHIEF vs PLD: Dividend Comparison 2026

SHIEF yields 1862.20% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SHIEF wins by $5120631284.58M in total portfolio value
10 years
SHIEF
SHIEF
● Live price
1862.20%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5120631290.49M
Annual income
$4,631,389,680,995,866.00
Full SHIEF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — SHIEF vs PLD

📍 SHIEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHIEFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHIEF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SHIEF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHIEF
Annual income on $10K today (after 15% tax)
$158,286.78/yr
After 10yr DRIP, annual income (after tax)
$3,936,681,228,846,486.00/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, SHIEF beats the other by $3,936,681,224,808,369.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHIEF + PLD for your $10,000?

SHIEF: 50%PLD: 50%
100% PLD50/50100% SHIEF
Portfolio after 10yr
$2560315648.20M
Annual income
$2,315,694,842,873,295.50/yr
Blended yield
90.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

SHIEF
No analyst data
Altman Z
-6.0
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHIEF buys
0
PLD buys
0
No recent congressional trades found for SHIEF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHIEFPLD
Forward yield1862.20%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$5120631290.49M$5.91M
Annual income after 10y$4,631,389,680,995,866.00$4,750,725.19
Total dividends collected$5085707947.59M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: SHIEF vs PLD ($10,000, DRIP)

YearSHIEF PortfolioSHIEF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$196,920$186,219.74$11,241$540.96+$185.7KSHIEF
2$3,637,839$3,427,134.81$13,019$991.13+$3.62MSHIEF
3$63,062,495$59,170,007.70$15,801$1,870.97+$63.05MSHIEF
4$1,026,094,767$958,617,897.05$20,609$3,701.21+$1026.07MSHIEF
5$15,675,254,453$14,577,333,052.44$29,919$7,867.97+$15675.22MSHIEF
6$224,896,168,169$208,123,645,903.83$50,631$18,617.74+$224896.12MSHIEF
7$3,031,287,183,467$2,790,648,283,526.89$105,528$51,352.20+$3031287.08MSHIEF
8$38,396,797,790,639$35,153,320,504,328.56$287,364$174,449.42+$38396797.50MSHIEF
9$457,235,149,060,462$416,150,575,424,478.80$1,081,760$774,280.77+$457235147.98MSHIEF
10$5,120,631,290,490,560$4,631,389,680,995,866.00$5,908,209$4,750,725.19+$5120631284.58MSHIEF

SHIEF vs PLD: Complete Analysis 2026

SHIEFStock

Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of clinical stage pharmaceuticals to treat unmet medical needs. The company's lead product is Accrufer/Feraccru, a non-salt based oral therapy for the treatment of iron deficiency with or without anemia in adults. It also develops PT20, a novel iron-based phosphate binder that has completed its Phase II pivotal study for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company was founded in 2008 and is based in Gateshead, the United Kingdom.

Full SHIEF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this SHIEF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHIEF vs SCHDSHIEF vs JEPISHIEF vs OSHIEF vs KOSHIEF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.